Selene Veerman
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 12
- Bipolar Disorder and Treatment 3
- Attention Deficit Hyperactivity Disorder 1
-
- Tryptophan and brain disorders 4
- Co-authors
- Peter F.J. Schulte (9 shared papers)Lieuwe de Haan (6 shared papers)Justin D. Smith (1 shared paper)Martin Begemann (2 shared papers)Jan Bogers (3 shared papers)Dan Cohen (2 shared papers)J.B. Deijen (1 shared paper)Dan Cohen (1 shared paper)
- Journals
- Pharmacopsychiatry (4 papers)Psychological Medicine (2 papers)Drugs (1 paper)Schizophrenia Bulletin (1 paper)Schizophrenia Research (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Selene Veerman
12 papers receiving 253 citations
Peers
Comparison fields: 5 of 53
- Biological Psychiatry 77
- Psychiatry and Mental health 170
- Pharmacology 51
- Philosophy 27
- Experimental and Cognitive Psychology 29
Countries citing papers authored by Selene Veerman
This map shows the geographic impact of Selene Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selene Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selene Veerman more than expected).
Fields of papers citing papers by Selene Veerman
This network shows the impact of papers produced by Selene Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selene Veerman. The network helps show where Selene Veerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Selene Veerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 57 | |
| 2 | 2016 | 54 | |
| 3 | 2014 | 29 | |
| 4 | 2014 | 26 | |
| 5 | 2021 | 25 | |
| 6 | 2016 | 17 | |
| 7 | 2022 | 15 | |
| 8 | 2014 | 14 | |
| 9 | 2021 | 14 | |
| 10 | 2023 | 4 | |
| 11 | [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate]. | 2010 | 2 |
| 12 | Pharmacological interventions in clozapine-refractory schizophrenia | 2017 | 1 |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 |
About Selene Veerman
Selene Veerman is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Pharmacology, Cellular and Molecular Neuroscience and Infectious Diseases, having authored 14 papers that have together received 258 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (12 papers), Tryptophan and brain disorders (4 papers), Bipolar Disorder and Treatment (3 papers), Treatment of Major Depression (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Metabolism and Genetic Disorders (1 paper) and Attention Deficit Hyperactivity Disorder (1 paper). The work is most often cited by research in Biological Psychiatry (77 citations), Psychiatry and Mental health (170 citations), Pharmacology (51 citations), Philosophy (27 citations) and Experimental and Cognitive Psychology (29 citations). Selene Veerman has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Peter F.J. Schulte, Lieuwe de Haan, Justin D. Smith, Martin Begemann, Jan Bogers, Dan Cohen, J.B. Deijen, Dan Cohen, Nico van Beveren and Sanne Koops. Their work appears in journals such as Pharmacopsychiatry, Psychological Medicine, Drugs, Schizophrenia Bulletin and Schizophrenia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.